FDA Acting Commissioner Schwetz Pledges To Maintain Agency Science Base
Acting FDA Commissioner Bernard Schwetz, PhD, will continue to make a priority of funding the agency's science base, he said in a Jan. 22 email to agency staff.
Acting FDA Commissioner Bernard Schwetz, PhD, will continue to make a priority of funding the agency's science base, he said in a Jan. 22 email to agency staff.